Search Results - "Dorr, Robert T."

Refine Results
  1. 1

    Pharmacokinetics and Safety of Green Tea Polyphenols after Multiple-Dose Administration of Epigallocatechin Gallate and Polyphenon E in Healthy Individuals by SHERRY CHOW, H.-H, YAN CAI, HAKIM, Iman A, CROWELL, James A, SHAHI, Farah, BROOKS, Chris A, DORR, Robert T, HARA, Yukihiko, ALBERTS, David S

    Published in Clinical cancer research (15-08-2003)
    “…Purpose: Green tea and green tea polyphenols have been shown to possess cancer preventive activities in preclinical model systems. In preparation for future…”
    Get full text
    Journal Article
  2. 2

    Mitochondrial-mediated disregulation of Ca2+ is a critical determinant of velcade (PS-341/bortezomib) cytotoxicity in myeloma cell lines by LANDOWSKI, Terry H, MEGLI, Christina J, NULLMEYER, Kevin D, LYNCH, Ronald M, DORR, Robert T

    Published in Cancer research (Chicago, Ill.) (01-05-2005)
    “…The proteasome inhibitor bortezomib (also known as PS-341/Velcade) is a dipeptidyl boronic acid that has recently been approved for use in patients with…”
    Get full text
    Journal Article
  3. 3

    Characterization of novel diaryl oxazole-based compounds as potential agents to treat pancreatic cancer by Shaw, Arthur Y, Henderson, Meredith C, Flynn, Gary, Samulitis, Betty, Han, Haiyong, Stratton, Steve P, Chow, H-H Sherry, Hurley, Laurence H, Dorr, Robert T

    “…A series of diaryl- and fluorenone-based analogs of the lead compound UA-62784 [4-(5-(4-methoxyphenyl)oxazol-2-yl)-9H-fluoren-9-one] was synthesized with the…”
    Get more information
    Journal Article
  4. 4

    Imexon induces an oxidative endoplasmic reticulum stress response in pancreatic cancer cells by Sheveleva, Elena V, Landowski, Terry H, Samulitis, Betty K, Bartholomeusz, Geoffrey, Powis, Garth, Dorr, Robert T

    Published in Molecular cancer research (01-03-2012)
    “…Oxidative protein folding in the endoplasmic reticulum (ER) requires strict regulation of redox homeostasis. Disruption of the lumenal redox balance induces an…”
    Get full text
    Journal Article
  5. 5

    Magnetic Resonance Imaging Identifies Differential Response to Pro-Oxidant Chemotherapy in a Xenograft Model by Landowski, Terry H, Guntle, Gerald P, Zhao, Dezheng, Jagadish, Bhumasamudram, Mash, Eugene A, Dorr, Robert T, Raghunand, Natarajan

    Published in Translational oncology (01-06-2016)
    “…Abstract Induction of oxidative stress is a key component of cancer therapy. Pro-oxidant drugs have been demonstrated to enhance the efficacy of radiotherapy…”
    Get full text
    Journal Article
  6. 6

    UA62784, a novel inhibitor of centromere protein E kinesin-like protein by Henderson, Meredith C, Shaw, Yeng-Jeng Y, Wang, Hong, Han, Haiyong, Hurley, Laurence H, Flynn, Gary, Dorr, Robert T, Von Hoff, Daniel D

    Published in Molecular cancer therapeutics (01-01-2009)
    “…Pancreatic carcinoma is the fourth leading cause of death from cancer. Novel targets and therapeutic options are needed to aid in the treatment of pancreatic…”
    Get full text
    Journal Article
  7. 7

    Ethonafide-induced cytotoxicity is mediated by topoisomerase II inhibition in prostate cancer cells by Pourpak, Alan, Landowski, Terry H, Dorr, Robert T

    “…Ethonafide is an anthracene-containing derivative of amonafide that belongs to the azonafide series of anticancer agents. The lack of cross-resistance in…”
    Get more information
    Journal Article
  8. 8

    Synthesis, characterization, and anti-melanoma activity of tetra-O-substituted analogs of nordihydroguaiaretic acid by Meyers, Ross O., Lambert, Joshua D., Hajicek, Nicole, Pourpak, Alan, Kalaitzis, John A., Dorr, Robert T.

    Published in Bioorganic & medicinal chemistry letters (15-08-2009)
    “…Novel derivatives of nordihydoguaiaretic acid were synthesized and tested for in vitro and in vivo anticancer activity. Synthesis of seven semi-synthetic…”
    Get full text
    Journal Article
  9. 9

    Nordihydroguaiaretic acid: hepatotoxicity and detoxification in the mouse by Lambert, Joshua D, Zhao, Dedun, Meyers, Ross O, Kuester, Robert K, Timmermann, Barbara N, Dorr, Robert T

    Published in Toxicon (Oxford) (01-12-2002)
    “…Larrea tridentata (Moc & Sess) Cov. (Zygophyllaceae) is an ethnobotanically important plant found in the American Southwest and northern Mexico. Although…”
    Get full text
    Journal Article
  10. 10

    Gemcitabine resistant pancreatic cancer cell lines acquire an invasive phenotype with collateral hypersensitivity to histone deacetylase inhibitors by Samulitis, Betty K, Pond, Kelvin W, Pond, Erika, Cress, Anne E, Patel, Hitendra, Wisner, Lee, Patel, Charmi, Dorr, Robert T, Landowski, Terry H

    Published in Cancer biology & therapy (01-01-2015)
    “…Gemcitabine based treatment is currently a standard first line treatment for patients with advanced pancreatic cancer, however overall survival remains poor,…”
    Get full text
    Journal Article
  11. 11

    Induction of oxidative stress and apoptosis in myeloma cells by the aziridine-containing agent imexon by Dvorakova, Katerina, Payne, Claire M, Tome, Margaret E, Briehl, Margaret M, McClure, Thomas, Dorr, Robert T

    Published in Biochemical pharmacology (15-09-2000)
    “…Imexon is an iminopyrrolidone derivative that has selective antitumor activity in multiple myeloma. The exact mechanism of imexon action is unknown. In human…”
    Get full text
    Journal Article
  12. 12

    New Perspectives on an Old Friend: Optimizing Carboplatin for the Treatment of Solid Tumors by Alberts, David S., Dorr, Robert T.

    Published in The oncologist (Dayton, Ohio) (01-02-1998)
    “…Background. Since its clinical introduction in 1981, carboplatin has proved a feasible alternative to cisplatin for the treatment of many solid tumors,…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Melanocortin peptide therapeutics: Historical milestones, clinical studies and commercialization by Hadley, Mac E., Dorr, Robert T.

    Published in Peptides (New York, N.Y. : 1980) (01-04-2006)
    “…The melanocortins (MCs) are a family of multifunctional peptidergic hormones. Several superpotent, prolonged acting, enzymatically resistant, MC analogs have…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Preventing the autophagic survival response by inhibition of calpain enhances the cytotoxic activity of bortezomib in vitro and in vivo by Escalante, Aluvia M., McGrath, Ryan T., Karolak, Matthew R., Dorr, Robert T., Lynch, Ronald M., Landowski, Terry H.

    Published in Cancer chemotherapy and pharmacology (01-06-2013)
    “…Purpose Bortezomib, a first-generation proteasome inhibitor, induces an endoplasmic reticulum (ER) stress response, which ultimately leads to dysregulation of…”
    Get full text
    Journal Article
  17. 17

    The diaryl oxazole PC-046 is a tubulin-binding agent with experimental anti-tumor efficacy in hematologic cancers by Landowski, Terry H., Samulitis, Betty K., Dorr, Robert T.

    Published in Investigational new drugs (01-12-2013)
    “…Summary Microtubule targeting agents are among the most widely used chemotherapeutics for both solid and hematological malignancies. This study characterizes…”
    Get full text
    Journal Article
  18. 18

    Synthesis and Antitumor Activity of Heterocycles Related to Carbendazim by Remers, William A., Iyengar, Bhashyam S., Dorr, Robert T., Wisner, Lee, Bates, Robert B.

    Published in Journal of heterocyclic chemistry (01-01-2015)
    “…Three types of compounds were synthesized from carbendazim (1), a benzimidazole derivative (Scheme ). They included a group of esters at N1 prepared by…”
    Get full text
    Journal Article
  19. 19

    Anti-tumor activity and mechanism of action for a cyanoaziridine-derivative, AMP423 by Dorr, Robert T., Wisner, Lee, Samulitis, Betty K., Landowski, Terry H., Remers, William A.

    Published in Cancer chemotherapy and pharmacology (01-04-2012)
    “…Purpose Preclinical studies evaluated the anti-tumor activity and mechanism of action of AMP423, a naphthyl derivative of 2-cyanoaziridine-1-carboxamide with…”
    Get full text
    Journal Article
  20. 20

    Interaction of Dacarbazine and Imexon, In Vitro and In Vivo, in Human A375 Melanoma Cells by SAMULITIS, Betty K, DORR, Robert T, CHOW, H.-H. Sherry

    Published in Anticancer research (01-09-2011)
    “…We evaluated mechanisms of interaction between the alkyating agent dacarbazine (DTIC) and the pro-oxidant, imexon, in the human A375 melanoma cell line. The…”
    Get full text
    Journal Article